Seres Therapeutics, Inc. Available-for-sale Securities, Gross Unrealized Loss
Seres Therapeutics, Inc. (MCRB) reported Available-for-sale Securities, Gross Unrealized Loss of $3.00 thousand for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLoss · last filed 2015-08-10
- 2015-06-30: Available-for-sale Securities, Gross Unrealized Loss 6 month $3.00K.
| Period end | Available-for-sale Securities, Gross Unrealized Loss 6 month |
|---|---|
| 2015-06-30 | $3.00K 10-Q · filed 2015-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |